Reduced Apaf-1 levels in cardiomyocytes engage strict regulation of apoptosis by endogenous XIAP

Journal of Cell Biology

Volumn 171, Issue 6, 2005, Pages 925-930

  Potts, Malia B ^a   Vaughn, Allyson E ^b   McDonough, Holly ^b   Patterson, Cam ^b   Deshmukh, Mohanish ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE; CYTOCHROME C; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVATION; HEART MUSCLE CELL; MICROINJECTION; MITOSIS; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; RAT; REDUCTION; REGULATORY MECHANISM;

ANIMALS; APOPTOSIS; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; CASPASES; CELLS, CULTURED; CYTOCHROMES C; CYTOSOL; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICROINJECTIONS; MICROSCOPY, FLUORESCENCE; MYOCYTES, CARDIAC; PROTEINS; RATS; TIME FACTORS; TRANSFECTION; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

ANIMALIA; MAMMALIA;

EID: 29144469495     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.200504082     Document Type: Article

References (32)

1. Anversa, P., A. Leri, J. Kajstura, and B. Nadal-Ginard. 2002. Myocyte growth and cardiac repair. J. Mol. Cell. Cardiol. 34:91-105.
2. Brustugun, O.T., K.E. Fladmark, S.O. Doskeland, S. Orrenius, and B. Zhivotovsky. 1998. Apoptosis induced by microinjection of cytochrome c is caspase-dependent and is inhibited by Bcl-2. Cell Death Differ. 5:660-668.
3. Burgess, D.H., M. Svensson, T. Dandrea, K. Gronlund, F. Hammarquist, S. Orrenius, and I.A. Cotgreave. 1999. Human skeletal muscle cytosols are refractory to cytochrome c-dependent activation of type-II caspases and lack APAF-1. Cell Death Differ. 6:256-261.
4. Chai, J., C. Du, J.W. Wu, S. Kyin, X. Wang, and Y. Shi. 2000. Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature. 406:855-862.
5. Chang, S.H., P.C. Phelps, I.K. Berezesky, M.J. Ebersberger, and B.F. Trump. 2000. Studies on the mechanisms and kinetics of apoptosis induced by microinjection of cytochrome c in rat kidney tubule epithelial cells (NRK-52E). Am. J. Pathol. 156:637-649.
6. Clerk, A., S.M. Cole, T.E. Cullingford, J.G. Harrison, M. Jormakka, and D.M. Valks. 2003. Regulation of cardiac myocyte cell death. Pharmacol. Ther. 97:223-261.
7. Deshmukh, M., and E.M. Johnson Jr. 1998. Evidence of a novel event during neuronal death: development of competence-to-die in response to cytoplasmic cytochrome c. Neuron. 21:695-705.
8. Deshmukh, M., C. Du, X. Wang, and E.M. Johnson Jr. 2002. Exogenous smac induces competence and permits caspase activation in sympathetic neurons. J. Neurosci. 22:8018-8027.
9. Deveraux, Q.L., and J.C. Reed. 1999. IAP family proteins - suppressors of apoptosis. Genes Dev. 13:239-252.
10. Ellerby, H.M., S.J. Martin, L.M. Ellerby, S.S. Naiem, S. Rabizadeh, G.S. Salvesen, C.A. Casiano, N.R. Cashman, D.R. Green, and D.E. Bredesen. 1997. Establishment of a cell-free system of neuronal apoptosis: comparison of premitochondrial, mitochondrial, and postmitochondrial phases. J. Neurosci. 17:6165-6178.
11. Flink, I.L., S. Oana, N. Maitra, J.J. Bahl, and E. Morkin. 1998. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes. J. Mol. Cell. Cardiol. 30:563-578.
12. Foo, R.S., K. Mani, and R.N. Kitsis. 2005. Death begets failure in the heart. J. Clin. Invest. 115:565-571.
13. Fuentes-Prior, P., and G.S. Salvesen. 2004. The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem. J. 384:201-232.
14. Garg, S., J. Narula, and Y. Chandrashekhar. 2005. Apoptosis and heart failure: clinical relevance and therapeutic target. J. Mol. Cell. Cardiol. 38:73-79.
15. Gill, C., R. Mestril, and A. Samali. 2002. Losing heart: the role of apoptosis in heart disease - a novel therapeutic target? FASEB J. 16:135-146.
16. Harlin, H., S.B. Reffey, C.S. Duckett, T. Lindsten, and C.B. Thompson. 2001. Characterization of XIAP-deficient mice. Mol. Cell. Biol. 21:3604-3608.
17. Hengartner, M.O. 2000. The biochemistry of apoptosis. Nature. 407:770-776.
18. Hu, Y., M.A. Benedict, L. Ding, and G. Nunez. 1999. Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis. EMBO J. 18:3586-3595.
19. Juin, P., A.O. Hueber, T. Littlewood, and G. Evan. 1999. c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev. 13:1367-1381.
20. Kluck, R.M., W.E. Bossy, D.R. Green, and D.D. Newmeyer. 1997. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1132-1136.
21. Li, F., A. Srinivasan, Y. Wang, R.C. Armstrong, K.J. Tomaselli, and L.C. Fritz. 1997. Cell-specific induction of apoptosis by microinjection of cytochrome c. Bcl-XL has activity independent of cytochrome c release. J. Biol. Chem. 272:30299-30305.
22. Liu, X., C.N. Kim, J. Yang, R. Jemmerson, and X. Wang. 1996. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 86:147-157.
23. Moroni, M.C., E.S. Hickman, E.L. Denchi, G. Caprara, E. Colli, F. Cecconi, H. Muller, and K. Helin. 2001. Apaf-1 is a transcriptional target for E2F and p53. Nat. Cell Biol. 3:552-558.
24. Narula, J., P. Pandey, E. Arbustini, N. Haider, N. Narula, F.D. Kolodgie, B.B. Dal, M.J. Semigran, M.A. Bielsa, G.W. Dec, et al. 1999. Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc. Natl. Acad. Sci. USA. 96:8144-8149.
25. Neame, S.J., L.L. Rubin, and K.L. Philpott. 1998. Blocking cytochrome c activity within intact neurons inhibits apoptosis. J. Cell Biol. 142:1583-1593.
26. Potts, P.R., S. Singh, M. Knezek, C.B. Thompson, and M. Deshmukh. 2003. Critical function of endogenous XIAP in regulating caspase activation during sympathetic neuronal apoptosis. J. Cell Biol. 163:789-799.
27. Salvesen, G.S., and C.S. Duckett. 2002. IAP proteins: blocking the road to death's door. Nat. Rev. Mol. Cell Biol. 3:401-410.
28. Sanchis, D., M. Mayorga, M. Ballester, and J.X. Comella. 2003. Lack of Apaf-1 expression confers resistance to cytochrome c-driven apoptosis in cardiomyocytes. Cell Death Differ. 10:977-986.
29. Scheubel, R.J., B. Bartling, A. Simm, R.E. Silber, K. Drogaris, D. Darmer, and J. Holtz. 2002. Apoptotic pathway activation from mitochondria and death receptors without caspase-3 cleavage in failing human myocardium: fragile balance of myocyte survival? J. Am. Coll. Cardiol. 39:481-488.
30. Wang, X. 2001. The expanding role of mitochondria in apoptosis. Genes Dev. 15:2922-2933.
31. Wright, K.M., M.W. Linhoff, P.R. Potts, and M. Deshmukh. 2004. Decreased apoptosome activity with neuronal differentiation sets the threshold for strict IAP regulation of apoptosis. J. Cell Biol. 167:303-313.
32. Yakovlev, A.G., K. Ota, G. Wang, V. Movsesyan, W.-L. Bao, K. Yoshihara, and A.I. Faden. 2001. Differential expression of apoptotic proteaseactivating factor-1 and caspase-3 genes and susceptibility to apoptosis during brain development and after traumatic brain injury. J. Neurosci. 21:7439-7446.